2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer

Dumont, Sander; Vandecaveye, Vincent; Dresen, Raphaëla C.; Nieuwenhuysen, Els Van; Baert, Thaïs; Han, Sileny; Neven, Patrick; Berteloot, Patrick; Amant, Frédéric; Gorp, Toon Van

doi:10.1136/ijgc-2022-esgo.583

Search citation statements

Order By: Relevance

Paper Sections

Select...

Ovarian Cancer1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a study presented by Sander Dumont, the authors examined the effectiveness of whole-body diffusion-weighted MRI combined with two prediction models for resectability during secondary cytoreductive surgery for relapsed epithelial ovarian cancer 25. This retrospective analysis included 246 patients treated between 2012 and 2021; of these, 124 (50.4%) patients qualified for secondary cytoreductive surgery based on radiological findings.…”

Section: Ovarian Cancermentioning

confidence: 99%

Best original research presented at the 23rd European Congress on Gynaecological Oncology—Best of ESGO 2022

Kacperczyk‐Bartnik

Bizzarri

Ángeles

et al. 2022

Int J Gynecol Cancer

View full text Add to dashboard Cite

Best of ESGO 2022 includes a selection of best original research presented during the 23rd European Congress on Gynaecological Oncology between October 27 and 30, 2022 in Berlin. Out of 1107 submitted abstracts, authors of studies which obtained the highest scores in a blinded review process were invited to present their results during four oral sessions, young investigators session, and oral poster sessions. By means of this publication, we aim to provide readers with an overview of the best quality research presented at the European Society of Gynaecological Oncology (ESGO) 2022.

show abstract

Section: Ovarian Cancermentioning

confidence: 99%